Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.
about
Treatment of Huntington's disease.Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortPhonatory dysfunction as a preclinical symptom of Huntington disease.Objective acoustic quantification of phonatory dysfunction in Huntington's diseaseJPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family.Motor onset and diagnosis in Huntington disease using the diagnostic confidence level.Onset symptoms in 510 patients with Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.The epidemiology of Huntington's disease in Northern Ireland.Progression in prediagnostic Huntington disease.Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease.Intact ability to learn internal models of arm dynamics in Huntington's disease but not cerebellar degeneration.Neuroprotective possibilities for Huntington's disease.POTENTIAL APPLICATION OF GRAPE DERIVED POLYPHENOLS IN HUNTINGTON'S DISEASEMotor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study.Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses.Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance.New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease.Huntington's Disease and Striatal Signaling.Movement sequencing in Huntington disease.Subtle changes among presymptomatic carriers of the Huntington's disease gene.Reflexive and volitional saccades: biomarkers of Huntington disease severity and progressionIntra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic BurdenMonitoring Huntington's disease progression through preclinical and early stagesDetection of Huntington's disease decades before diagnosis: the Predict-HD studyTen-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onsetHuntington's disease. Part 1: essential background and management.Patient and caregiver quality of life in Huntington's diseaseProgression of motor subtypes in Huntington's disease: a 6-year follow-up study.Clinical and genetic investigation of a Brazilian family with Huntington's disease.The clinical and genetic features of Huntington disease.Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q.The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials.Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?Rate of change in early Huntington's disease: a clinicometric analysis.
P2860
Q26782004-7C739B61-BB58-4435-923B-BC9F91BFEE32Q28538703-84FB1CF9-FAAA-4C08-BA63-6DF5F989F614Q30425545-5EFA9B48-B492-464E-B12E-F23DF279F2C7Q30453596-11EBEB29-3011-4E3D-A787-6E55D7E2430CQ30515533-8254AE4D-4AFE-4283-9518-B76016198091Q30684587-808CF6D9-26DD-4696-B975-A94049835634Q33595188-255F4322-9B81-4389-99D8-1E7FF2626EFCQ33606063-FBAACC68-5870-4982-A32E-0420F8404997Q33677085-F0A43749-6109-45DB-BC7E-5027C73CCD37Q33861265-893F50DB-0398-4AA3-9723-3D9C062D221FQ34184185-D289CA14-489D-4B4D-8983-4B00C7584C99Q34215149-7AAF5A46-2A8D-4492-9880-691B0CC572D0Q34273178-5ACA40B5-F9BF-41BF-BB4D-93B65BC2BC43Q34380485-37D6351A-B999-4182-B98E-139CB83AC7D1Q34451995-66DEA473-E55A-4EDC-B8C4-E708B05AF90FQ34576042-1BDABF70-1DC9-4BD6-B85B-1B19F31BBE72Q34624765-3C193A8A-CA47-4069-89D8-2D0C521BD576Q34733147-4B1D0B94-171B-48EC-B1AE-5516F4E63DF8Q34917383-7C36E285-C659-4C93-A6FA-B80BEE8862A0Q35173848-ED39E782-BE3C-49EB-97EF-FC489FA474A9Q35243890-69442A7E-FC23-4406-8D88-838044C5BB85Q35286098-F266F993-24D0-4214-8CF8-10112C0C9259Q35312436-12600E30-5B9A-4699-A234-AF1A88EB3BE9Q35460244-903D39C9-67CD-4AF6-8AC5-50ECA4EE8864Q35663482-F2E3A86F-401F-4240-9AD1-61D3E28C8229Q35997096-8DC409EA-A766-4CAB-8648-4A84B99ABB31Q36459201-45011D00-30E1-4414-BAA3-1F37A2919EEAQ36941187-E8C41115-9F73-4734-89EC-C3898BDA2FEAQ36992068-DBBD3D90-250F-4450-8AB9-6012537AD8AAQ37073913-561B0464-4E27-4ABF-86EA-69E627E4180AQ37139088-1CB09485-8E19-4AAD-A849-AC54C8683ECAQ37212835-856CD216-7EFD-400E-8626-6523F059B082Q37284637-35FB2870-1826-455B-BCD2-E7C983BECC94Q37422838-714E39A7-D5C4-4BFB-B41E-E00729B94EE0Q37798079-F076456A-0A40-4F14-85EA-EB05481CBAEBQ37965763-22B41B85-F652-41A1-8232-1CC192096198Q38202178-7D48D936-87E4-4122-8FE9-F19C08621BAFQ38244078-AE60CF15-F282-49D3-BECF-2EC197A5C386Q38843644-63D38C47-AE08-4118-A527-BA2041A7EE40Q39685633-626D1780-3D11-4FF6-99E8-05457926D990
P2860
Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Huntington's disease in Venezu ...... and asymptomatic individuals.
@en
Huntington's disease in Venezu ...... and asymptomatic individuals.
@nl
type
label
Huntington's disease in Venezu ...... and asymptomatic individuals.
@en
Huntington's disease in Venezu ...... and asymptomatic individuals.
@nl
prefLabel
Huntington's disease in Venezu ...... and asymptomatic individuals.
@en
Huntington's disease in Venezu ...... and asymptomatic individuals.
@nl
P2093
P2860
P356
P1433
P1476
Huntington's disease in Venezu ...... and asymptomatic individuals.
@en
P2093
Penchaszadeh G
Penney JB Jr
Ramos-Arroyo M
Sanchez-Ramos J
Shoulson I
Snodgrass SR
Starosta-Rubenstein S
P2860
P356
10.1002/MDS.870050202
P407
P577
1990-01-01T00:00:00Z